| Identification | Back Directory | [Name]
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide | [CAS]
2758097-38-8 | [Synonyms]
DOG-IM4
N-[(25Z)-14-[(9Z)-9-Octadecen-1-yloxy]-3,6,9,12,16-pentaoxatetratriacont-25-en-1-yl]-1H-imidazole-5-carboxamide | [Molecular Formula]
C51H95N3O7 | [MOL File]
2758097-38-8.mol | [Molecular Weight]
862.32 |
| Chemical Properties | Back Directory | [Boiling point ]
882.3±65.0 °C(Predicted) | [density ]
0.972±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [solubility ]
Ethanol: 10 mg/ml | [pka]
11.73±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
DOG-IM4 can be used to synthesize nanoparticles to deliver antigen-encoding nucleic acids. It could be used to try to target autoimmune diseases, rare blood or metabolic diseases, allergies, cancer or infectious diseases[1]. | [References]
[1] Synthesis of lipids for nanoparticle delivery of therapeutic agents. World Intellectual Property Organization, WO2022013443 A1 2022-01-20. |
|
|